Compare AU

Compare JRHG vs. DRUG

Compare shares and ETFs on the ASX that you can trade on Pearler.

Jpmorgan Gl Re En In Eqh Active ETF (Managed Fund)

ASX

Buy

Buy

Overview
Performance

Overview

When it comes to investing in the Australian stock market, shares and ETFs are a popular choice. Two options in the ASX are JRHG and DRUG. In this comparison, we'll delve into these options across various dimensions to help you make an informed investment decision.

Community Stats

JRHG

DRUG

Popularity

N/A

Low

Pearlers invested

0

65

Median incremental investment

$0

$990.50

Median investment frequency

N/A

Monthly

Median total investment

$0

$1,933.47

Average age group

N/A

26 - 35


Key Summary

JRHG

DRUG

Strategy

JRHG.AX was created on 2023-11-16 by JPMorgan. The fund's investment portfolio concentrates primarily on total market equity.

DRUG.AX was created on 2016-08-04 by BetaShares. The fund's investment portfolio concentrates primarily on health care equity. DRUG.AX aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars.

Top 3 holdings

Jpmorgan Gl Re En In Eqh Active ETF (Managed Fund) (100 %)

CHF - SWISS FRANC (0 %)

AUD - AUSTRALIA DOLLAR (0 %)

DKK - DANISH KRONE (0 %)

Top 3 industries

Other (75.53 %)

Communication Services (33.53 %)

Health Care (24.47 %)

Top 3 countries

United States (71.71 %)

Switzerland (8.14 %)

Denmark (6.30 %)

Management fee

0.3 %

0.57 %


Key Summary

JRHG

DRUG

Issuer

JPMorgan

BetaShares

Tracking index

MSCI World ex Australia - AUD - Benchmark TR Net Hedged

Nasdaq Global ex-Australia Healthcare Hedged AUD Index - AUD

Asset class

ETF

ETF

Management fee

0.3 %

0.57 %

Price

$64.56

$8.37

Size

N/A

$182.401 million

10Y return

N/A

N/A

Annual dividend/ distribution yield (5Y)

0.14 %

1.90 %

Market

ASX

ASX

First listed date

15/11/2023

08/08/2016

Purchase fee

$6.50

$6.50


Community Stats

JRHG

DRUG

Popularity

N/A

Low

Pearlers invested

0

65

Median incremental investment

$0

$990.50

Median investment frequency

N/A

Monthly

Median total investment

$0

$1,933.47

Average age group

N/A

26 - 35


Pros and Cons

JRHG

DRUG

Pros

  • Lower management fee

  • Higher exposure to US market

  • Higher price growth

  • Higher distribution yield

Cons

  • Lower exposure to US market

  • Lower price growth

  • Lower distribution yield

  • Higher management fee

JRHG

DRUG

Lower exposure to US market

Higher exposure to US market

Lower management fee

Higher management fee

Lower price growth

Higher price growth

Lower distribution yield

Higher distribution yield

Home